{"id":12784,"date":"2026-02-18T13:51:00","date_gmt":"2026-02-18T13:51:00","guid":{"rendered":"https:\/\/csiag.de\/?p=12784"},"modified":"2026-04-05T15:41:39","modified_gmt":"2026-04-05T15:41:39","slug":"fotobiomodulering-pbm","status":"publish","type":"post","link":"https:\/\/csiag.de\/sv\/blog\/2026\/02\/18\/photobiomodulation-pbm\/","title":{"rendered":"Fotobiomodulering (PBM)"},"content":{"rendered":"<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_86 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title\" style=\"cursor:inherit\">Inneh\u00e5llsf\u00f6rteckning<\/p>\n<span class=\"ez-toc-title-toggle\"><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/csiag.de\/sv\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Einleitung\" >Inledning<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/csiag.de\/sv\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Indikationen_auf_einen_Blick\" >Indikationer vid en \u00f6verblick<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/csiag.de\/sv\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Haut_Wundheilung_Kollagen_660_nm\" >Hud, s\u00e5rl\u00e4kning och kollagen (660 nm)<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/csiag.de\/sv\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Ubergreifende_Reviews_Mechanismen\" >Omfattande granskningar och mekanismer<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/csiag.de\/sv\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Kollagensynthese_Hautverjungung\" >Kollagensyntes och hudf\u00f6ryngring<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/csiag.de\/sv\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Klinische_Studien_Wundheilung_JAAD\" >Kliniska studier S\u00e5rl\u00e4kning (JAAD)<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/csiag.de\/sv\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Muskeln_Sport_Rehabilitation_850_nm\" >Muskler, sport och rehabilitering (850 nm)<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/csiag.de\/sv\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Skelettmuskelregeneration\" >Regenerering av skelettmuskulatur<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/csiag.de\/sv\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Meta-Analysen_Sportleistung_Muskelkater\" >Metaanalyser av idrottsprestationer och muskel\u00f6mhet<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/csiag.de\/sv\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Gehirn_Kognition_Neurologie_810%E2%80%931064_nm\" >Hj\u00e4rna, kognition och neurologi (810-1.064 nm)<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/csiag.de\/sv\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Mechanismen_allgemeine_Wirkungen\" >Mekanismer och allm\u00e4nna effekter<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/csiag.de\/sv\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Alzheimer_Demenz\" >Alzheimers sjukdom och demens<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/csiag.de\/sv\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#TBI_Entgiftung_1064_nm\" >TBI &amp; avgiftning (1.064 nm)<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/csiag.de\/sv\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Schmerzmanagement\" >Sm\u00e4rtlindring<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/csiag.de\/sv\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Ubergreifende_Reviews\" >Omfattande recensioner<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/csiag.de\/sv\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Fibromyalgie\" >Fibromyalgi<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/csiag.de\/sv\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Kniearthrose_Tendinopathie\" >Artros och tendinopati i kn\u00e4<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/csiag.de\/sv\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Neuropathischer_Schmerz\" >Neuropatisk sm\u00e4rta<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/csiag.de\/sv\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Augenheilkunde_AMD\" >Oftalmologi (AMD)<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-20\" href=\"https:\/\/csiag.de\/sv\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Altersbedingte_Makuladegeneration\" >\u00c5ldersrelaterad makuladegeneration<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-21\" href=\"https:\/\/csiag.de\/sv\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Onkologie_Mukositis\" >Onkologi och mukosit<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-22\" href=\"https:\/\/csiag.de\/sv\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Leitlinien\" >Riktlinjer<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-23\" href=\"https:\/\/csiag.de\/sv\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Chemotherapie-induzierte_Mukositis\" >Slemhinneinflammation orsakad av kemoterapi<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-24\" href=\"https:\/\/csiag.de\/sv\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Kopf-Hals-Karzinome_Strahlentherapie\" >Huvud- och halscancer &amp; str\u00e5lbehandling<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-25\" href=\"https:\/\/csiag.de\/sv\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Immunsystem_Entzundung\" >Immunsystem &amp; inflammation<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-26\" href=\"https:\/\/csiag.de\/sv\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Immunmodulation\" >Immunmodulering<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-27\" href=\"https:\/\/csiag.de\/sv\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Klinische_Empfehlungen\" >Kliniska rekommendationer<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-28\" href=\"https:\/\/csiag.de\/sv\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Allgemeine_Dosierungsregeln_Konsensus\" >Allm\u00e4nna doseringsregler (konsensus)<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-29\" href=\"https:\/\/csiag.de\/sv\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Evidenzstarke_nach_Bereich\" >Styrkan i bevisen per omr\u00e5de<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-30\" href=\"https:\/\/csiag.de\/sv\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Kontakt_zu_PBM-Anwendern_%E2%80%93_Arzte_Kliniken\" >Kontakt med PBM-anv\u00e4ndare - l\u00e4kare\/kliniker<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-31\" href=\"https:\/\/csiag.de\/sv\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Augenheilkunde_%E2%80%93_Trockene_AMD_Makuladegeneration\" >Oftalmologi - Torr AMD (makuladegeneration)<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-32\" href=\"https:\/\/csiag.de\/sv\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Onkologie_%E2%80%93_Orale_Mukositis_Chemo-Strahlentherapiefolge\" >Onkologi - Oral mukosit (konsekvens av kemoterapi\/str\u00e5lbehandling)<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-33\" href=\"https:\/\/csiag.de\/sv\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Dermatologie_%E2%80%93_Haut_Wundheilung_Akne_Psoriasis\" >Dermatologi - hud, s\u00e5rl\u00e4kning, akne, psoriasis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-34\" href=\"https:\/\/csiag.de\/sv\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Zahnmedizin_MKG-Chirurgie\" >Tandv\u00e5rd \/ maxillofacial kirurgi<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-35\" href=\"https:\/\/csiag.de\/sv\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Neurologie_Psychiatrie_%E2%80%93_Alzheimer_TBI_Depression_fruhe_Phase\" >Neurologi \/ Psykiatri - Alzheimers, TBI, depression (tidig fas)<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-36\" href=\"https:\/\/csiag.de\/sv\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Allgemeine_Suchwerkzeuge\" >Allm\u00e4nna s\u00f6kverktyg<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n\n<p class=\"wp-block-paragraph\">Omfattande \u00f6versikt \u00f6ver studien 2023-2025<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Einleitung\"><\/span>Inledning<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Fotobiomodulering (PBM), \u00e4ven k\u00e4nd som l\u00e5gniv\u00e5laserterapi (LLLT), \u00e4r en icke-invasiv terapeutisk metod som anv\u00e4nder ljus med specifika v\u00e5gl\u00e4ngder f\u00f6r att stimulera biologiska processer i levande v\u00e4vnad.<br>Den prim\u00e4ra mekanismen \u00e4r absorptionen av fotoner av den mitokondriella fotoacceptorn <em>Cytokrom c-oxidas<\/em> (CCO), som \u00e4r den <em>ATP-syntes<\/em> modulerar reaktiva syref\u00f6reningar och utl\u00f6ser en kaskad av cellul\u00e4ra regenereringsprocesser.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Det terapeutiskt relevanta \u201eoptiska f\u00f6nstret\u201c ligger mellan 600 och 1.100 nm. Tre kliniskt s\u00e4rskilt viktiga v\u00e5gl\u00e4ngder \u00e4r:<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>660 nm<\/strong><br>Penetrationsdjup 1-10 mm, effektt\u00e4thet 6-50 mW\/cm\u00b2<br>Idealisk f\u00f6r hud, s\u00e5rl\u00e4kning och ytlig v\u00e4vnad.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>850 nm<\/strong><br>Intr\u00e4ngningsdjup upp till 50 mm, effektt\u00e4thet 50-100 mW\/cm\u00b2<br>L\u00e4mplig f\u00f6r muskler, leder och djupare strukturer.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>1.050-1.064 nm<\/strong><br>Djup v\u00e4vnadspenetration, effektt\u00e4thet 25-285 mW\/cm\u00b2 (transkraniell)<br>Relevant f\u00f6r neurologi, hj\u00e4rnan och oftalmologi.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Den grundl\u00e4ggande principen f\u00f6r dosbest\u00e4mning f\u00f6ljer <em>Arndt-Schulz-kurvan<\/em> (Hormesis):<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>F\u00f6r lite ljus har ingen effekt, den optimala dosen stimulerar<\/li>\n\n\n\n<li>F\u00f6r mycket har en h\u00e4mmande till cellskadande effekt.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Detta bifasiska f\u00f6rh\u00e5llande f\u00f6rklarar varf\u00f6r r\u00e4tt effektt\u00e4thet och energit\u00e4thet \u00e4r avg\u00f6rande f\u00f6r en framg\u00e5ngsrik behandling.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Indikationen_auf_einen_Blick\"><\/span>Indikationer vid en \u00f6verblick<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">I f\u00f6ljande tabell sammanfattas de parametrar som anv\u00e4nts i kliniska studier (v\u00e5gl\u00e4ngd, effektt\u00e4thet, energit\u00e4thet, varaktighet, frekvens) f\u00f6r varje behandlingsomr\u00e5de. <br>K\u00e4llor: Hamblin\/Harvard (<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8355782\/\" target=\"_blank\" rel=\"noreferrer noopener\">PMC8355782<\/a>), <a href=\"https:\/\/waltpbm.org\/\" target=\"_blank\" rel=\"noopener\">WALT-riktlinjer<\/a>, kliniska pr\u00f6vningar 2020-2025.<\/p>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><td><strong>Indikation<\/strong><\/td><td><strong>V\u00e5gl\u00e4ngd<\/strong><\/td><td><strong>Effektt\u00e4thet<\/strong><\/td><td><strong>Energit\u00e4thet<\/strong><\/td><td><strong>Varaktighet \/ session<\/strong><\/td><td><strong>frekvens<\/strong><\/td><\/tr><\/thead><tbody><tr><td>Hud \/ Kollagen<\/td><td>660 nm<\/td><td>6-50 mW\/cm\u00b2<\/td><td>8-16 J\/cm\u00b2<\/td><td>10-21 minuter<\/td><td>2-3\u00d7\/vecka<\/td><\/tr><tr><td>s\u00e5rl\u00e4kning<\/td><td>630-660 nm<\/td><td>10-50 mW\/cm\u00b2<\/td><td>4-15 J\/cm\u00b2<\/td><td>7-20 minuter<\/td><td>dagligen - 3\u00d7\/vecka<\/td><\/tr><tr><td>Muskelregenerering<\/td><td>808-850 nm<\/td><td>50-100 mW\/cm\u00b2<\/td><td>10-30 J\/cm\u00b2<\/td><td>5-15 minuter<\/td><td>direkt f\u00f6re\/efter sport<\/td><\/tr><tr><td>Kronisk sm\u00e4rta<\/td><td>630-905 nm<\/td><td>40-100 mW\/cm\u00b2<\/td><td>4-10 J\/cm\u00b2<\/td><td>10-20 minuter<\/td><td>3\u00d7\/vecka, 6-12 veckor.<\/td><\/tr><tr><td>Fibromyalgi<\/td><td>630-1.100 nm (hela kroppen)<\/td><td>variabel<\/td><td>1-150 J\/cm\u00b2<\/td><td>15-30 minuter<\/td><td>2-3\u00d7\/vecka, 4-6 veckor.<\/td><\/tr><tr><td>Artros i kn\u00e4<\/td><td>630-850 nm<\/td><td>40-80 mW\/cm\u00b2<\/td><td>4-10 J\/cm\u00b2<\/td><td>10-20 minuter<\/td><td>3\u00d7\/vecka<\/td><\/tr><tr><td>Hj\u00e4rna \/ Kognition<\/td><td>810-1 064 nm (transkraniell)<\/td><td>25-285 mW\/cm\u00b2<\/td><td>20-60 J\/cm\u00b2<\/td><td>10-20 minuter<\/td><td>3\u00d7\/vecka<\/td><\/tr><tr><td>AMD \/ \u00d6gon<\/td><td>590 + 660 + 850 nm<\/td><td>0,3-15 \u03bcW\/cm\u00b2 (n\u00e4thinnan)<\/td><td>Mycket l\u00e5g<\/td><td>3-10 min \/ session<\/td><td>3\u00d7\/vecka till dagligen<\/td><\/tr><tr><td>Mukosit (onkologi)<\/td><td>630-660 nm<\/td><td>10-25 mW\/cm\u00b2<\/td><td>2-6 J\/cm\u00b2<\/td><td>3-5 min\/punkt<\/td><td>dagligen under behandlingen<\/td><\/tr><tr><td>Immunmodulering \/ inflammation<\/td><td>650-950 nm<\/td><td>variabel<\/td><td>1-10 J\/cm\u00b2<\/td><td>5-15 minuter<\/td><td>3\u00d7\/vecka<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\"><em>Effektt\u00e4thet = irradians (mW\/cm\u00b2) vid v\u00e4vnadsytan.<\/em><br><em>Energit\u00e4thet = fluens (J\/cm\u00b2) per session.<\/em><br><em>AMD: Bestr\u00e5lningsv\u00e4rdena f\u00f6r n\u00e4thinnan \u00e4r betydligt l\u00e4gre \u00e4n v\u00e4rdena f\u00f6r hudytan.<\/em><br><em><strong>Varsel<\/strong>Ingen enhetlig internationell standard - v\u00e4rdena \u00e5terspeglar konsensus fr\u00e5n metaanalyser och WALT:s rekommendationer.<\/em><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Haut_Wundheilung_Kollagen_660_nm\"><\/span>Hud, s\u00e5rl\u00e4kning och kollagen (660 nm)<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">R\u00f6tt ljus vid 660 nm absorberas s\u00e4rskilt effektivt av hudens kromoforer och aktiverar kollagensyntesen i fibroblaster via uppreglering av COL1A1- och COL3A1-genuttryck samt MMP-9- och NO-fris\u00e4ttning. Penetrationsdjup: 1-10 mm (epidermis, dermis, hypodermis). Det bifasiska dosm\u00f6nstret \u00e4r s\u00e4rskilt uttalat i hudv\u00e4vnad: energidensiteter \u00f6ver 20 J\/cm\u00b2 kan utl\u00f6sa oxidativ stress och omv\u00e4nd kollagenstimulering.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>parameter<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>V\u00e5gl\u00e4ngd 660 nm (\u00e4ven 630-680 nm)<\/li>\n\n\n\n<li>Effektt\u00e4thet 6-50 mW\/cm\u00b2 (LED: 6-30; laser: 30-50)<\/li>\n\n\n\n<li>Energit\u00e4thet 8-16 J\/cm\u00b2 (optimal)<\/li>\n\n\n\n<li>Varaktighet 10-21 min | 3\u00d7 per vecka<\/li>\n\n\n\n<li>Minst 8 veckor f\u00f6r hudf\u00f6ryngring; 4 veckor f\u00f6r s\u00e5rl\u00e4kning<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Ubergreifende_Reviews_Mechanismen\"><\/span>Omfattande granskningar och mekanismer<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Fr\u00e5n ljus till l\u00e4kning: Fotobiomodulationsbehandling inom medicinska discipliner<\/strong><br><em>Journal of Translational Medicine (2025)<\/em><a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12751248\/\" target=\"_blank\" rel=\"noopener\"> Fulltext \/ PubMed<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Omfattande genomg\u00e5ng som kombinerar fotofysik, mitokondriell biologi och klinisk rehabilitering. PBM vid 600-1.100 nm aktiverar \u00f6kad ATP-syntes och kontrollerad ROS-signalering via CCO, vilket aktiverar transkriptionsfaktorer (NF-\u03baB, AP-1, HIF-1\u03b1) och uppreglerar tillv\u00e4xtfaktorer (TGF-\u03b2, VEGF, IGF-1). P\u00e5 v\u00e4vnadsniv\u00e5 fr\u00e4mjas fibroblast- och keratinocytproliferation, makrofagpolarisering och kollagensyntes. Viktigaste dosrekommendationen f\u00f6r v\u00e4vnader med l\u00e5gt mitokondrieinneh\u00e5ll (hud, senor): Effektt\u00e4thet &lt; 100 mW\/cm\u00b2, energit\u00e4thet 4-10 J\/cm\u00b2 vid m\u00e5lv\u00e4vnaden.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Uppl\u00e5sning av ljusets kraft p\u00e5 huden: En omfattande genomg\u00e5ng av fotobiomodulering<\/strong><br><em>Int. J. Mol. Sci. (2024)<\/em> <a href=\"https:\/\/www.mdpi.com\/1422-0067\/25\/8\/4483\" target=\"_blank\" rel=\"noopener\">Fulltext \/ PubMed<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Narrativ genomg\u00e5ng av kliniska studier (6 \u00e5r) p\u00e5 PBM inom dermatologi. 630-950 nm anv\u00e4ndes mest frekvent. Optimalt f\u00f6r hudf\u00f6ryngring: 630-660 nm, 6-50 mW\/cm\u00b2, 8-16 J\/cm\u00b2, 3\u00d7\/vecka. Bikini-bifasisk effekt: B\u00e4st resultat med m\u00e5ttliga mellandoser; \u00f6verdosering (&gt;20 J\/cm\u00b2 p\u00e5 hudytan) kan h\u00e4mma kollagensyntesen i st\u00e4llet f\u00f6r att fr\u00e4mja den.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Kollagensynthese_Hautverjungung\"><\/span>Kollagensyntes och hudf\u00f6ryngring<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Optimering av l\u00e5gniv\u00e5ljusbehandling f\u00f6r hudf\u00f6ryngring<\/strong><br><em>SCIRP (2025)<\/em> <a href=\"https:\/\/www.scirp.org\/journal\/paperinformation?paperid=142513\" target=\"_blank\" rel=\"noopener\">Fulltext \/ PubMed<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">RCT (split-face) med 830 nm + 633 nm LED. Parametrar: 6,4 mW\/cm\u00b2, 8,05 J\/cm\u00b2, 21 minuter per session, 3\u00d7\/vecka i 4 veckor. Signifikant minskning av rynkor och f\u00f6rb\u00e4ttrad hudelasticitet. Viktigt resultat: 3 sessioner per vecka var mer effektiva \u00e4n 2 - frekvensen p\u00e5verkade resultatet starkt.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Reglering av hudens kollagenmetabolism med hj\u00e4lp av 660 nm LED<\/strong><br><em>Journal of Investigative Dermatology (klassisk studie)<\/em><a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0022202X15341749\" target=\"_blank\" rel=\"noopener\"> Fulltext \/ PubMed<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>parameter<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>660 nm, pulsad (LED f\u00f6r sekventiellt pulsl\u00e4ge)<\/li>\n\n\n\n<li>11 m\u00f6ten<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Resultat<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>+31% Typ 1-prokollagen<\/li>\n\n\n\n<li>-18% MMP-1 i v\u00e4vnadsbiopsier.<\/li>\n\n\n\n<li>&gt;90% av testpersonerna uppvisade en minskning av rynkdjupet.<\/li>\n\n\n\n<li>Det sekventiella pulsm\u00f6nstret (inte kontinuerlig v\u00e5g) var avg\u00f6rande f\u00f6r den fotobiologiska effekten.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Klinische_Studien_Wundheilung_JAAD\"><\/span>Kliniska studier S\u00e5rl\u00e4kning (JAAD)<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Fotobiomodulering CME del II: Kliniska till\u00e4mpningar inom dermatologi<\/strong><br><em>Journal of the American Academy of Dermatology (2024)<\/em> <a href=\"https:\/\/www.jaad.org\/article\/S0190-9622(24)00187-7\/fulltext\" target=\"_blank\" rel=\"noopener\">Fulltext \/ PubMed<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Samf\u00f6rst\u00e5nd mellan &gt;20 experter (JAAD). Parametrar f\u00f6r diabetess\u00e5r (evidensniv\u00e5 IA): 630-670 nm, 10-50 mW\/cm\u00b2, 2-6 J\/cm\u00b2, daglig applicering eller 3\u00d7\/vecka tills s\u00e5ret l\u00e4ker. Metaanalys av 12 RCT: s\u00e5ryta -30,9%, -4,2 cm\u00b2 j\u00e4mf\u00f6rt med kontroll. Alla s\u00e5rl\u00e4kningsfaser (inflammatorisk, proliferativ, remodellering) p\u00e5verkas positivt.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Effekt av PBM-behandling (660 nm) p\u00e5 s\u00e5rl\u00e4kning infekterad av Staphylococcus aureus<\/strong><br><em>Fotobiomodul Fotomed Laser Surg. (2020)<\/em> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/32466696\/\" target=\"_blank\" rel=\"noopener\">Fulltext \/ PubMed<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Djurstudie: 660 nm, 35 min\/dag, 7 dagar. Signifikant mindre s\u00e5r (p &lt; 0,01), mer granulationsv\u00e4vnad, h\u00f6gsta kollagenhalt (grad 3+). PCNA-mark\u00f6rer f\u00f6r proliferation \u00f6kade signifikant. Obs: Intensiteten h\u00f6lls avsiktligt l\u00e5g - f\u00f6r infekterade s\u00e5r \u00e4r det s\u00e4rskilt viktigt att inte \u00f6verskrida dosen (&lt; 15 J\/cm\u00b2).<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Muskeln_Sport_Rehabilitation_850_nm\"><\/span>Muskler, sport och rehabilitering (850 nm)<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">N\u00e4ra infrar\u00f6tt ljus vid 850 nm tr\u00e4nger in upp till 50 mm djupt. Enligt en metaanalys (Baroni et al., 2019) \u00e4r den optimala parametern f\u00f6r muskelapplikationer 810 nm, 100 mW\/cm\u00b2, 30 J\/cm\u00b2 - 15% styrke\u00f6kning uppm\u00e4ttes hos tr\u00e4nade idrottare. Om doserna \u00e4r f\u00f6r h\u00f6ga (&gt;50 J\/cm\u00b2, &gt;200 mW\/cm\u00b2) minskar effekterna. I studien av Leal-Junior et al (2011) fastst\u00e4lldes den optimala dosen f\u00f6r 810 nm till 30 J totalt (inte J\/cm\u00b2) under 6 muskelpunkter f\u00f6re tr\u00e4ning.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>parameter<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>V\u00e5gl\u00e4ngd 808-850 nm<\/li>\n\n\n\n<li>Effektt\u00e4thet 50-100 mW\/cm\u00b2 (laser); 30-150 mW\/cm\u00b2 (LED-panel)<\/li>\n\n\n\n<li>Energit\u00e4thet 10-30 J\/cm\u00b2 (idrottare); 6-10 J\/cm\u00b2 (rehabilitering)<\/li>\n\n\n\n<li>Varaktighet 5-15 min\/muskelgrupp<br>Anv\u00e4nd direkt f\u00f6re eller efter tr\u00e4ning<\/li>\n\n\n\n<li>3-7\u00d7\/vecka f\u00f6r intensiv tr\u00e4ning; 2-3\u00d7 f\u00f6r rehabilitering<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Skelettmuskelregeneration\"><\/span>Regenerering av skelettmuskulatur<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>PBMT vid regenerering av skelettmuskler: omfattande granskning<\/strong><br><em>Fotodiagnostik och fotodynamisk terapi (2025)<\/em> <a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1572100025001668\" target=\"_blank\" rel=\"noopener\">Fulltext \/ PubMed<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Nyckelstudie (Baroni 2019): 810 nm, 100 mW\/cm\u00b2, 30 J\/cm\u00b2, 6 muskelpunkter \u2192 15% styrke\u00f6kning hos idrottare. IL-6-reduktion med 40% med f\u00f6rebyggande PBM (5 J\/cm\u00b2 p\u00e5 tibialis hos r\u00e5tta). Varning: Parametrar fr\u00e5n djurstudier (t.ex. 5 J\/cm\u00b2) \u00e4r inte direkt \u00f6verf\u00f6rbara till m\u00e4nniskor - quadriceps hos m\u00e4nniskor kr\u00e4ver h\u00f6gre energit\u00e4thet p\u00e5 grund av st\u00f6rre v\u00e4vnadsdjup.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>PBM i m\u00e4nsklig muskelv\u00e4vnad: en f\u00f6rdel vid idrottsprestationer?<\/strong><br><em>J. Biofotonik (PMC) (2016)<\/em> <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC5167494\/\" target=\"_blank\" rel=\"noopener\">Fulltext \/ PubMed<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Systematisk genomg\u00e5ng av alla RCT (niv\u00e5 1b) och fall-kontrollstudier (niv\u00e5 3b). De mest effektiva parametrarna f\u00f6r biceps: 810-850 nm, 50-100 mW\/cm\u00b2, 10-30 J\/cm\u00b2. Effektivaste parametrarna f\u00f6r quadriceps (st\u00f6rre muskel, djupare v\u00e4vnad): h\u00f6gre energier kr\u00e4vs, klusterapplikatorer (5 dioder) f\u00f6redras. F\u00f6rtr\u00e4ning med PBM \u00e4r minst likv\u00e4rdig och ofta \u00f6verl\u00e4gsen applicering efter tr\u00e4ning n\u00e4r det g\u00e4ller styrkev\u00e4rden.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Meta-Analysen_Sportleistung_Muskelkater\"><\/span>Metaanalyser av idrottsprestationer och muskel\u00f6mhet<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Effekter av fotomodulationsbehandling f\u00f6r DOMS: Systematisk granskning och metaanalys<\/strong><br><em>MDPI JFMK (2025)<\/em> <a href=\"https:\/\/www.mdpi.com\/2411-5142\/10\/3\/277\" target=\"_blank\" rel=\"noopener\">Fulltext \/ PubMed<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">14 studier, v\u00e5gl\u00e4ngder 660-950 nm, 1-6 muskelpunkter. Optimalt f\u00f6r DOMS-reduktion: 830-850 nm, 50-100 mW\/cm\u00b2, 6-10 J\/cm\u00b2 per punkt, direkt efter tr\u00e4ning. Signifikant VAS-sm\u00e4rtreduktion j\u00e4mf\u00f6rt med placebo; positiva effekter p\u00e5 bibeh\u00e5llen muskelstyrka.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Kan PBM f\u00f6re tr\u00e4ning f\u00f6rb\u00e4ttra muskeluth\u00e5lligheten och fr\u00e4mja \u00e5terh\u00e4mtning? Meta-analys<\/strong><br><em>Lasrar inom medicinsk vetenskap (2024)<\/em> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38758297\/\" target=\"_blank\" rel=\"noopener\">Fulltext \/ PubMed<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Kreatinkinas minskade med 77,56 enheter (95%-KI: -112,67 till -42,44, p &lt; 0,01). De mest effektiva parametrarna: 810 nm, 200 mW total effekt, 30 J total energi till 6 quadriceps-punkter. Bifasiskt resultat: 50 J totalt var mindre effektivt \u00e4n 30 J - tydligt exempel p\u00e5 Hormesis\/Arndt-Schulz-kurvan.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>PBM f\u00f6re tr\u00e4ning (810 nm): Optimalt effektuttag f\u00f6r muskel\u00e5terh\u00e4mtning<\/strong><br><em>Photomed Laser Surg (2017)<\/em> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/29099680\/\" target=\"_blank\" rel=\"noopener\">Fulltext \/ PubMed<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">RCT med 28 fotbollsspelare. J\u00e4mf\u00f6rde 100, 200, 400 mW effekt per diod (5 dioder, 810 nm). Resultat: 100 mW\/diod (500 mW totalt) var optimalt. H\u00f6gre effekt (200, 400 mW) gav inte b\u00e4ttre eller till och med s\u00e4mre resultat - ett klassiskt exempel: h\u00f6gre effektt\u00e4thet \u00e4r inte automatiskt b\u00e4ttre.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Effekter av PBM, IPC och NMES p\u00e5 muskel\u00e5terh\u00e4mtning: Systematisk genomg\u00e5ng<\/strong><br><em>Journal of Bodywork and Movement Therapies (2025)<\/em> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40954632\/\" target=\"_blank\" rel=\"noopener\">Fulltext \/ PubMed<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">19 RCT, 672 deltagare. PBM f\u00f6re tr\u00e4ning minskade sm\u00e4rtan med -12,27 po\u00e4ng (95%-KI -18,14 till -6,40; I\u00b2 = 48%). PBM var den enda metoden (j\u00e4mf\u00f6rt med IPC och NMES) med signifikant nytta. Rekommenderade parametrar: 810-850 nm, 50-100 mW\/cm\u00b2, 6-10 J\/cm\u00b2.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Gehirn_Kognition_Neurologie_810%E2%80%931064_nm\"><\/span>Hj\u00e4rna, kognition och neurologi (810-1.064 nm)<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Transkraniell PBM m\u00e5ste \u00f6vervinna flera biologiska barri\u00e4rer (skalp, skallben, hj\u00e4rnhinnor, cerebrospinalv\u00e4tska, cortex). De effektt\u00e4theter som kr\u00e4vs \u00e4r d\u00e4rf\u00f6r betydligt h\u00f6gre \u00e4n f\u00f6r ytliga till\u00e4mpningar. En systematisk genomg\u00e5ng fr\u00e5n 2024 (97 studier, 2 133 k\u00e4llor) visade f\u00f6ljande: I studier anv\u00e4nds vanligtvis ~250 mW\/cm\u00b2 p\u00e5 ytan - varav endast en br\u00e5kdel n\u00e5r hj\u00e4rnv\u00e4vnaden. F\u00f6r kortikala neuroner: optimal ATP-produktion vid 25 mW\/cm\u00b2, 3 J\/cm\u00b2. Mitokondriell skada uppstod redan vid 30 J\/cm\u00b2 (f\u00f6r h\u00f6g dos = h\u00e4mmande).<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>parameter<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>V\u00e5gl\u00e4ngd 810 nm (kognition\/Alzheimers), 1.064 nm (djup penetration\/TBI)<\/li>\n\n\n\n<li>Effektt\u00e4thet 25-285 mW\/cm\u00b2 vid h\u00e5rbotten (m\u00e5lv\u00e4vnad: cortex f\u00e5r en br\u00e5kdel av detta)<\/li>\n\n\n\n<li>Energit\u00e4thet 20-60 J\/cm\u00b2 (yta); 3 J\/cm\u00b2 vid m\u00e5lv\u00e4vnaden (nervceller)<\/li>\n\n\n\n<li>Varaktighet 10-20 min | 3\u00d7\/vecka (12 veckor f\u00f6r RCT-unders\u00f6kningar om Alzheimers sjukdom)<\/li>\n\n\n\n<li>Minst 8-12 veckor f\u00f6r kognitiva effekter; akuta effekter fr\u00e5n 1-2 veckor f\u00f6r TBI<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Mechanismen_allgemeine_Wirkungen\"><\/span>Mekanismer och allm\u00e4nna effekter<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Fotobiomoduleringsterapi p\u00e5 hj\u00e4rnan: Revolutionera den kognitiva dynamiken<\/strong><br><em>MDPI Cells (2024)<\/em> <a href=\"https:\/\/www.mdpi.com\/2073-4409\/13\/11\/966\" target=\"_blank\" rel=\"noopener\">Fulltext \/ PubMed<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">PBM aktiverar cytokrom c-oxidas i neuronala mitokondrier, \u00f6kar BDNF. 810 nm visar starkare CCO-aktivering \u00e4n 1 064 nm (CCO-absorptionstopp vid ~810 nm). 1 064 nm har \u00e5 andra sidan ett starkare inflytande p\u00e5 Ca\u00b2\u207a-kanaler. Konsensus om kliniska parametrar: 810 nm, 250 mW\/cm\u00b2 yta, 20-60 J\/cm\u00b2, transkraniellt p\u00e5 prefrontala cortex och temporalloben.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Brain PBM Narrativ granskning: Mekanismer, doser, framtida trender<\/strong><br><em>PMC (Brain Photobiomodulation Review) (2018)<\/em> <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6041198\/\" target=\"_blank\" rel=\"noopener\">Fulltext \/ PubMed<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Viktiga parametrar: Kortikala neuroner (odlade): 25 mW\/cm\u00b2, optimal ATP-produktion vid 3 J\/cm\u00b2. H\u00f6gre doser (10 J\/cm\u00b2) stimulerar mindre, 30 J\/cm\u00b2 leder till mitokondriell skada. F\u00f6r djupare hj\u00e4rnregioner (basala ganglier, hj\u00e4rnstam vid Parkinsons sjukdom): Klass 4-laser (10-15 W) rekommenderas i st\u00e4llet f\u00f6r klass 3 (&lt;0,5 W) f\u00f6r att ge tillr\u00e4cklig fluens p\u00e5 djupet.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Alzheimer_Demenz\"><\/span>Alzheimers sjukdom och demens<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Brain PBM: potentiell behandling av Alzheimers och Parkinsons sjukdom<\/strong><br><em>PMC (2025)<\/em> <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12321612\/\" target=\"_blank\" rel=\"noopener\">Fulltext \/ PubMed<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Prekliniska studier: 808-810 nm, pulsad (40 Hz), dagligen eller 3\u00d7\/vecka, 12 veckor. Visade minskning av amyloid beta, ox. Stress, neuroinflammation; b\u00e4ttre kognitiva resultat i djurmodell. Klinisk studie (Japan): pulserande 810 nm ljus (40 Hz), 3\u00d7\/vecka, 12 veckor, resultat: signifikant f\u00f6rb\u00e4ttrade ADAS-Cog-po\u00e4ng.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Transkraniell PBM vid Alzheimers sjukdom: RCT-protokoll (Japan)<\/strong><br><em>Gr\u00e4nser inom neurologi (2024)<\/em> <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11258032\/\" target=\"_blank\" rel=\"noopener\">Fulltext \/ PubMed<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Fullst\u00e4ndigt beskrivna RCT-parametrar: 810 nm, pulsad 40 Hz, 250 mW\/cm\u00b2, 20 min\/session, 3\u00d7\/vecka, 12 veckor. EEG-m\u00e4tningar visade f\u00f6rb\u00e4ttrad alfa\/beta\/gamma-rytm. Prim\u00e4rt effektm\u00e5tt ADAS-Cog (Alzheimer's Cognition Scale). Prospektiv sham-kontrollerad studie.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Transkraniell PBM f\u00f6rb\u00e4ttrar kognitiv funktion, PTSD och symtom efter hj\u00e4rnskakning<\/strong><br><em>Journal of Neurotrauma (2025)<\/em> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40485299\/\" target=\"_blank\" rel=\"noopener\">Fulltext \/ PubMed<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">RCT, 17 patienter med traumatisk hj\u00e4rnskada. Parametrar: 810 nm eller 1.064 nm, 250 mW\/cm\u00b2, 20 J\/cm\u00b2, 10 min\/session. Signifikanta f\u00f6rb\u00e4ttringar av kognitiv funktion, PTSD och post-concussion symptom. Placebo-kontrollerad.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"TBI_Entgiftung_1064_nm\"><\/span>TBI &amp; avgiftning (1.064 nm)<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>1064 nm PBM fr\u00e4mjar \u00e5terh\u00e4mtning fr\u00e5n TBI genom att modulera neuroinflammation<\/strong><br><em>Journal of Translational Medicine (2025)<\/em> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/41204266\/\" target=\"_blank\" rel=\"noopener\">Fulltext \/ PubMed<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Musmodell: 1.064 nm LED, 25 mW\/cm\u00b2, 12 min\/dag (= 18 J\/cm\u00b2), 14 dagar. Betydande \u00e5terh\u00e4mtning efter TBI, lindring av kognitiva och k\u00e4nslom\u00e4ssiga funktionsneds\u00e4ttningar. BDNF och VEGF \u00f6kade signifikant i behandlingsomr\u00e5det. Mekanism: Modulering av mikrogliapolarisering och neuroinflammation.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>PBM och det glymfatiska systemet: F\u00f6rb\u00e4ttrad lymfatisk dr\u00e4nering av hj\u00e4rnan<\/strong><br><em>Int. J. Mol. Sci. (2022)<\/em> <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8950470\/\" target=\"_blank\" rel=\"noopener\">Fulltext \/ PubMed<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Djurstudier: PBM (810 nm, 25-50 mW\/cm\u00b2) f\u00f6rb\u00e4ttrar lymffl\u00f6det i hj\u00e4rnhinnan och fr\u00e4mjar clearance av amyloid beta via det glymfatiska systemet. Terapeutisk implikation: Hj\u00e4rnans avgiftningsfunktion - relevant f\u00f6r att f\u00f6rebygga Alzheimers sjukdom och f\u00f6r hj\u00e4rnans allm\u00e4nna h\u00e4lsa.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Schmerzmanagement\"><\/span>Sm\u00e4rtlindring<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">PBM har en sm\u00e4rtstillande effekt via flera mekanismer: minskning av proinflammatoriska cytokiner (TNF-\u03b1, IL-6, IL-1\u03b2), modulering av nociceptiva C- och A\u03b4-fibrer, \u00f6kad endorfinfris\u00e4ttning och f\u00f6rb\u00e4ttring av den lokala mikrocirkulationen. F\u00f6r ytliga sm\u00e4rtpunkter (tender points, trigger points): 630-660 nm \u00e4r tillr\u00e4ckligt. F\u00f6r djupare muskuloskeletala strukturer (leder, ryggrad): 780-905 nm med h\u00f6gre effektt\u00e4thet.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>parameter<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>V\u00e5gl\u00e4ngd 630-905 nm (beroende p\u00e5 sm\u00e4rtpunktens djup)<\/li>\n\n\n\n<li>Effektt\u00e4thet 40-100 mW\/cm\u00b2 (ytlig: 40-60; djup: 60-100)<\/li>\n\n\n\n<li>Energit\u00e4thet 4-10 J\/cm\u00b2 per punkt (f\u00f6r fibromyalgi: upp till 150 J\/cm\u00b2 f\u00f6r hela kroppen)<\/li>\n\n\n\n<li>Varaktighet 10-20 min\/session<\/li>\n\n\n\n<li>Frekvens 3\u00d7\/vecka, 6-12 veckor; fibromyalgi: 4-6 veckor intensiv + uppf\u00f6ljning<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Ubergreifende_Reviews\"><\/span>Omfattande recensioner<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Effekter av PBM p\u00e5 flera h\u00e4lsoutfall: paraply\u00f6versikt av RCT-studier<\/strong><br><em>Systematiska \u00f6versikter (Springer) (2025)<\/em> <a href=\"https:\/\/link.springer.com\/article\/10.1186\/s13643-025-02902-3\" target=\"_blank\" rel=\"noopener\">Fulltext \/ PubMed<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">15 metaanalyser, &gt;9 000 patienter, 35 effektm\u00e5tt, 15 sjukdomar. Starkast evidens f\u00f6r fibromyalgi, funktionsneds\u00e4ttning vid kn\u00e4artros och kognitiv neds\u00e4ttning. PBM-protokollen varierade stort - det finns ingen enhetlig standard, vilket g\u00f6r j\u00e4mf\u00f6rbarheten sv\u00e5r. GRADE-kvalitet: 17% m\u00e5ttlig, 57% l\u00e5g, 26% mycket l\u00e5g.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>PBM vid kronisk sm\u00e4rta: Systematisk genomg\u00e5ng av RCT-studier<\/strong><br><em>Gr\u00e4nser inom integrativ neurovetenskap (2026)<\/em> <a href=\"https:\/\/www.frontiersin.org\/journals\/integrative-neuroscience\/articles\/10.3389\/fnint.2026.1717372\/full\" target=\"_blank\" rel=\"noopener\">Fulltext \/ PubMed<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">14 RCT, 6 611 artiklar granskade. Starkast resultat f\u00f6r fibromyalgi och perifera neuropatier: VAS-reduktion signifikant (p = 0,010), \u00f6mma punkter signifikant reducerade (p &lt; 0,0001). Rekommenderade parametrar f\u00f6r neuropatisk sm\u00e4rta: 660-830 nm, 40-80 mW\/cm\u00b2, 4-6 J\/cm\u00b2, 3 g\u00e5nger i veckan.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Fibromyalgie\"><\/span>Fibromyalgi<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Effektiviteten av PBMT vid fibromyalgi: Systematisk granskning (17 studier)<\/strong><br><em>MDPI Till\u00e4mpad vetenskap (2025)<\/em> <a href=\"https:\/\/www.mdpi.com\/2076-3417\/15\/8\/4161\" target=\"_blank\" rel=\"noopener\">Fulltext \/ PubMed<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">857 deltagare. Apparater som anv\u00e4ndes: l\u00e5gniv\u00e5laser, infrar\u00f6d LED, ljusb\u00e4ddar f\u00f6r hela kroppen (NovoTHOR). PBM p\u00e5 hela kroppen (630-1 100 nm, variabel fluens 1-150 J\/cm\u00b2) var minst likv\u00e4rdig med lokaliserad PBM. Mekanism: Modulering av oxidativ stress, mitokondriell funktion och nociceptiva signalv\u00e4gar. Rekommendation: Helkroppsbehandling \u00e4r att f\u00f6redra vid utbredda sm\u00e4rtpunkter.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>PBM f\u00f6r hela kroppen p\u00e5 sm\u00e4rta, livskvalitet, kinesiofobi: trippelblindad RCT, 6 m\u00e5naders uppf\u00f6ljning<\/strong><br><em>Gr\u00e4nser inom neurovetenskap (2024)<\/em> <a href=\"https:\/\/www.frontiersin.org\/journals\/neuroscience\/articles\/10.3389\/fnins.2024.1264821\/full\" target=\"_blank\" rel=\"noopener\">Fulltext \/ PubMed<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">42 patienter, NovoTHOR helkroppss\u00e4ng (660 + 850 nm, egenutvecklad effektt\u00e4thet). 12 behandlingstillf\u00e4llen. Signifikant sm\u00e4rtreduktion vid T2 (efter behandling), T3 (2-veckors uppf\u00f6ljning) och T4\/T5 (3 och 6 m\u00e5nader). PBM f\u00f6r hela kroppen behandlar systemisk fibromyalgi mer effektivt \u00e4n selektiv applicering.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Kniearthrose_Tendinopathie\"><\/span>Artros och tendinopati i kn\u00e4<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>PBM f\u00f6r kn\u00e4artros: Systematisk \u00f6versikt och metaanalys (10 RCT)<\/strong><br><em>Sjukgymnastik (2024)<\/em> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38775202\/\" target=\"_blank\" rel=\"noopener\">Fulltext \/ PubMed<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">542 deltagare. De mest effektiva parametrarna: 810-830 nm, 50-100 mW\/cm\u00b2, 4-10 J\/cm\u00b2 p\u00e5 kn\u00e4ledens ledspringa, 10-20 min, 3\u00d7\/vecka. M\u00e5ttliga bevis f\u00f6r sm\u00e4rtlindring och funktionsf\u00f6rb\u00e4ttring. Obs: Kn\u00e4leden \u00e4r djupare \u00e4n hudytan - d\u00e4rf\u00f6r \u00e4r 810-850 nm (djupare penetration) att f\u00f6redra framf\u00f6r 660 nm.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Neuropathischer_Schmerz\"><\/span>Neuropatisk sm\u00e4rta<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>PBM vid neuropatisk sm\u00e4rta: mekanismer, evidens och framtida inriktning<\/strong><br><em>Gr\u00e4nser inom fotonik (2025)<\/em> <a href=\"https:\/\/www.frontiersin.org\/journals\/photonics\/articles\/10.3389\/fphot.2025.1730347\/full\" target=\"_blank\" rel=\"noopener\">Fulltext \/ PubMed<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">660 nm aktiverar andra fotoacceptorer \u00e4n 810-850 nm. F\u00f6r ytlig neuropati (t.ex. postherpetisk neuralgi): 660 nm, 20-50 mW\/cm\u00b2, 4-6 J\/cm\u00b2. F\u00f6r djup neuropati (t.ex. diabetisk polyneuropati i f\u00f6tterna): 810-830 nm, 50-100 mW\/cm\u00b2, 6-10 J\/cm\u00b2. Mekanism: PBM inducerar neuroskydd via BDNF-syntes och undertryckande av neuroinflammation.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Augenheilkunde_AMD\"><\/span>Oftalmologi (AMD)<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">S\u00e4rskilda doseringsregler g\u00e4ller f\u00f6r \u00f6gonapplikationer (s\u00e4rskilt AMD): Retinal irradians (det som faktiskt n\u00e5r n\u00e4thinnan) \u00e4r drastiskt l\u00e4gre \u00e4n enhetens effektt\u00e4thet. Apparater som fotobiomoduleringsglas\u00f6gonen (LumiThera) avger ljus genom pupillen - direkt p\u00e5 makula. D\u00e4rf\u00f6r kan s\u00e5 lite som 0,3-15 \u03bcW\/cm\u00b2 retinal irradians vara tillr\u00e4ckligt. F\u00f6rsiktighet: Felaktig dosering kan orsaka n\u00e4thinneskador. Anv\u00e4nd endast godk\u00e4nda oftalmologiska PBM-enheter!<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>parameter<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>V\u00e5gl\u00e4ngd 590 nm + 660 nm + 850 nm (flera v\u00e5gl\u00e4ngder, t.ex. LIGHTSITE III)<\/li>\n\n\n\n<li>Effektt\u00e4thet 0,3-15 \u03bcW\/cm\u00b2 (n\u00e4thinna); enhet ~600 \u03bcW\/cm\u00b2 ytarea<\/li>\n\n\n\n<li>Mycket l\u00e5g energit\u00e4thet, noggrant kalibrerad<\/li>\n\n\n\n<li>Varaktighet 3-10 min\/session, 3\u00d7 per vecka under 3-13 m\u00e5nader<\/li>\n\n\n\n<li>L\u00e5ngvarig anv\u00e4ndning; kontroll var 3:e m\u00e5nad<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Altersbedingte_Makuladegeneration\"><\/span>\u00c5ldersrelaterad makuladegeneration<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>LIGHTSITE III: PBM (590+660+850 nm) med torr AMD<\/strong><br><em>RETINA Tidskrift (2024)<\/em> <a href=\"https:\/\/journals.lww.com\/retinajournal\/fulltext\/2024\/03000\/lightsite_iii__13_month_efficacy_and_safety.14.aspx\" target=\"_blank\" rel=\"noopener\">Fulltext \/ PubMed<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">100 patienter, 10 amerikanska center, 13 m\u00e5nader. Enhet: LumiThera Valeda Light Delivery System. V\u00e5gl\u00e4ngder: 590 + 660 + 850 nm sekventiellt. Behandling: 3\u00d7\/vecka i 3 m\u00e5nader, d\u00e4refter upprepade behandlingscykler. Resultat: +5,4 bokst\u00e4vers synsk\u00e4rpa (ETDRS) j\u00e4mf\u00f6rt med sham, &lt;1% ny geografisk atrofi j\u00e4mf\u00f6rt med 9,8% i sham-armen - statistiskt mycket signifikant.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>PBM4AMD: Korttidseffekt vid tidig\/intermedi\u00e4r AMD<\/strong><br><em>\u00d6gon (natur) (2024)<\/em> <a href=\"https:\/\/www.nature.com\/articles\/s41433-024-03326-4\" target=\"_blank\" rel=\"noopener\">Fulltext \/ PubMed<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">38 deltagare, 12 veckor. Parametrar: Multi-v\u00e5gl\u00e4ngdsbehandling (liknande LIGHTSITE), 10 min\/session, 3\u00d7\/vecka. Synsk\u00e4rpa, kontrastk\u00e4nslighet och m\u00f6rkeradaption f\u00f6rb\u00e4ttrades signifikant. S\u00e4kerhet: inga termiska eller strukturella biverkningar p\u00e5 n\u00e4thinnan.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>PBM-anv\u00e4ndning inom oftalmologi: fr\u00e5n b\u00e4nk till s\u00e4ng<\/strong><br><em>Gr\u00e4nser inom oftalmologi (2024)<\/em> <a href=\"https:\/\/www.frontiersin.org\/journals\/ophthalmology\/articles\/10.3389\/fopht.2024.1388602\/full\" target=\"_blank\" rel=\"noopener\">Fulltext \/ PubMed<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">F\u00f6rklarar den komplexa parametersituationen inom oftalmologi: retinal irradians \u00e4r avg\u00f6rande, inte enhetens effekt. Olika AMD-studier med 630 nm visade signifikanta f\u00f6rb\u00e4ttringar av n\u00e4thinnan redan vid 15 \u03bcW\/cm\u00b2. Inga biverkningar under 15 \u00e5r med korrekt dosering - viktigt: anv\u00e4nd endast kalibrerade medicintekniska produkter med \u00f6gonspecifika godk\u00e4nnanden.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Onkologie_Mukositis\"><\/span>Onkologi och mukosit<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Oral mukosit \u00e4r den vanligaste akuta biverkningen av kemoterapi\/str\u00e5lbehandling. PBM appliceras intraoralt p\u00e5 munslemhinnan som en f\u00f6rebyggande \u00e5tg\u00e4rd (f\u00f6re och under cancerbehandling). Enligt MASCC\/ISOO:s riktlinjer (2019) \u00e4r PBM den enda icke-farmakologiska \u00e5tg\u00e4rden med en formell rekommendation (niv\u00e5 A) f\u00f6r f\u00f6rebyggande av mukosit vid hematopoetisk stamcellstransplantation. V\u00e5gl\u00e4ngderna och doserna \u00e4r de mest standardiserade inom detta omr\u00e5de.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>parameter<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>V\u00e5gl\u00e4ngd 630-660 nm (intraoral); 650 + 980 nm (kombinerad intra+extraoral)<\/li>\n\n\n\n<li>Effektt\u00e4thet 10-25 mW\/cm\u00b2 (MASCC\/ISOO rekommenderar InGaAlP-lasrar 10-25 mW)<\/li>\n\n\n\n<li>Energit\u00e4thet 2-6 J\/cm\u00b2 per slemhinnepunkt<\/li>\n\n\n\n<li>Varaktighet 3-5 min\/punkt<br>Anv\u00e4nd dagligen eller omv\u00e4xlande under cancerbehandling<\/li>\n\n\n\n<li>Frekvens Dagligen under kemoterapi\/str\u00e5lbehandling; minst 5 g\u00e5nger per vecka<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Leitlinien\"><\/span>Riktlinjer<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>MASCC\/ISOO:s riktlinjer f\u00f6r klinisk praxis f\u00f6r PBM och oral mukosit<\/strong><br><em>Support Care Cancer (2019)<\/em> <a href=\"https:\/\/link.springer.com\/article\/10.1007\/s00520-019-04890-2\" target=\"_blank\" rel=\"noopener\">Fulltext \/ PubMed<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Formell rekommendation (h\u00f6gsta graden av evidens): V\u00e5gl\u00e4ngd 632-685 nm (He-Ne eller InGaAlP), effekt 10-25 mW, energit\u00e4thet 2-4 J\/cm\u00b2 per applikationspunkt, intraoralt p\u00e5 sjuka omr\u00e5den. Frekvens: dagligen under kemoterapi. G\u00e4ller f\u00f6r: hematopoetisk stamcellstransplantation, kemoradioterapi av huvud och hals. Inga signifikanta biverkningar efter 15 \u00e5rs uppf\u00f6ljning.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Chemotherapie-induzierte_Mukositis\"><\/span>Slemhinneinflammation orsakad av kemoterapi<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>F\u00f6rebyggande PBM f\u00f6r oral mukosit orsakad av kemoterapi: systematisk genomg\u00e5ng av RCT-studier<\/strong><br><em>MDPI Biomedicines (2025)<\/em> <a href=\"https:\/\/www.mdpi.com\/2227-9059\/13\/2\/268\" target=\"_blank\" rel=\"noopener\">Fulltext \/ PubMed<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">13 studier, 828 patienter. Parametrar som anv\u00e4nts: 630-660 nm InGaAlP diodlaser, 10-25 mW, 2-6 J\/cm\u00b2, intraoralt dagligen. 211 j\u00e4mf\u00f6rt med 128 patienter utvecklade mukosit (kontroll j\u00e4mf\u00f6rt med PBM). 85% av studierna hade l\u00e5g risk f\u00f6r bias. F\u00f6rebyggande PBM signifikant \u00f6verl\u00e4gsen reaktiv behandling.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>F\u00f6rbehandling med PBM f\u00f6r oral mukosit: dubbelblind RCT<\/strong><br><em>BMC Oral h\u00e4lsa (2025)<\/em> <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11800611\/\" target=\"_blank\" rel=\"noopener\">Fulltext \/ PubMed<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">45 patienter, 3 grupper. Grupp 2: intraoralt 650 nm (4 J\/cm\u00b2). Grupp 3: intraoral 650 nm + extraoral 980 nm. B\u00e5da interventionsgrupperna visade signifikant f\u00f6rebyggande av mukosit och xerostomi. Resultat: Kombinationen av r\u00f6tt och infrar\u00f6tt ljus (650 + 980 nm) \u00e4r maximalt effektiv f\u00f6r att t\u00e4cka hela munnen.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Kopf-Hals-Karzinome_Strahlentherapie\"><\/span>Huvud- och halscancer &amp; str\u00e5lbehandling<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>PBM f\u00f6r oral mukosit vid huvud- och halscancer: Metaanalys av 14 RCT-studier<\/strong><br><em>Huvud och hals (Wiley) (2024)<\/em> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38265122\/\" target=\"_blank\" rel=\"noopener\">Fulltext \/ PubMed<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">869 patienter. Parameteranalys: He-Ne- och InGaAlP-laser (630-660 nm), 10-25 mW, 2-6 J\/cm\u00b2, daglig applicering under str\u00e5lbehandling gav b\u00e4st resultat. Relativ riskreduktion f\u00f6r mukosit: RR = 0,49 (p = 0,04) fr\u00e5n vecka 2. Sm\u00e4rtreduktion: WMD = -1,09 (p &lt; 0,00001). Mycket signifikant effekt under 7 veckors str\u00e5lbehandling.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Immunsystem_Entzundung\"><\/span>Immunsystem &amp; inflammation<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">PBM p\u00e5verkar immunsystemet p\u00e5 ett kontextberoende s\u00e4tt: I inflammerad v\u00e4vnad har det en antiinflammatorisk effekt (minskar TNF-\u03b1, IL-6, IL-1\u03b2; fr\u00e4mjar M2-makrofagpolarisering), i frisk v\u00e4vnad har det en stimulerande effekt. Den immunmodulerande effekten har p\u00e5visats inom det optiska f\u00f6nstret (650-950 nm), med en doskorridor p\u00e5 1-10 J\/cm\u00b2. Viktigt: Dessa doser \u00e4r betydligt l\u00e4gre \u00e4n f\u00f6r muskelapplikationer - immunf\u00f6rsvaret reagerar mer k\u00e4nsligt.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>parameter<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>V\u00e5gl\u00e4ngd 650-950 nm (bredaste effektiva spektrum; kombinationen 660 + 850 nm rekommenderas)<\/li>\n\n\n\n<li>Effektt\u00e4thet 20-80 mW\/cm\u00b2<\/li>\n\n\n\n<li>Energit\u00e4thet 1-10 J\/cm\u00b2 (immunmodulering)<br>H\u00f6gre doser kan ha en immunh\u00e4mmande effekt<\/li>\n\n\n\n<li>Varaktighet 5-15 min\/session<\/li>\n\n\n\n<li>3\u00d7\/vecka; vid akut inflammation dagligen under den f\u00f6rsta veckan<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Immunmodulation\"><\/span>Immunmodulering<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Immunmodulerande effekter av PBM: omfattande granskning<\/strong><br><em>Lasrar inom medicinsk vetenskap (2025)<\/em> <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11991943\/\" target=\"_blank\" rel=\"noopener\">Fulltext \/ PubMed<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Optimala parametrar f\u00f6r immunmodulering: 650-950 nm, 20-80 mW\/cm\u00b2, 1-10 J\/cm\u00b2. PBM p\u00e5verkar dendritiska celler (migration, cytokinproduktion), fr\u00e4mjar M2-polarisering av makrofager och reglerar T-cellssvar. Viktigt resultat: Endast 1 J\/cm\u00b2 \u00e4r tillr\u00e4ckligt f\u00f6r m\u00e4tbara immunologiska effekter - l\u00e5ngt under de doser som rekommenderas f\u00f6r muskler\/ben.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Effekten av PBM-terapi vid behandling av sm\u00e4rta och inflammation: Litteratur\u00f6versikt<\/strong><br><em>PMC (2023)<\/em> <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10094541\/\" target=\"_blank\" rel=\"noopener\">Fulltext \/ PubMed<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">PBM 600-1.070 nm, energit\u00e4thet 1-150 J\/cm\u00b2. Optimal f\u00f6r inflammationsh\u00e4mning: 780-950 nm, 40-80 mW\/cm\u00b2, 4-10 J\/cm\u00b2, 3\u00d7\/vecka. PBM p\u00e5 hela kroppen visade systemiska immuneffekter: f\u00f6rb\u00e4ttrad s\u00f6mnkvalitet, morgonstelhet, minskning av muskelkramper, psykologiska faktorer. S\u00e4rskilt relevant f\u00f6r kroniska inflammatoriska systemiska sjukdomar (t.ex. fibromyalgi, RA).<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Genomg\u00e5ng av ljusparametrar och PBM-effektivitet (Hamblin, Harvard)<\/strong><br><em>J. Biomed. Optics (PMC) (2021)<\/em> <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8355782\/\" target=\"_blank\" rel=\"noopener\">Fulltext \/ PubMed<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Grundl\u00e4ggande arbete f\u00f6r att fastst\u00e4lla parametrar (Hamblin\/Harvard). Centralt uttalande: Ingen universell \u00f6verenskommelse om optimala parametrar - effektt\u00e4thet &lt; 100 mW\/cm\u00b2 och energit\u00e4thet 4-10 J\/cm\u00b2 vid m\u00e5lv\u00e4vnaden anses vara konsensus f\u00f6r konservativ rekommendation. Bifasisk dosrespons (Arndt-Schulz): cellstimulering mellan 0,5-10 J\/cm\u00b2, h\u00e4mning \u00f6ver ~30 J\/cm\u00b2. V\u00e4vnader med h\u00f6g mitokondriehalt (muskler, nerver, hj\u00e4rta, hj\u00e4rna) kr\u00e4ver mer energi \u00e4n v\u00e4vnader med l\u00e5g mitokondriehalt (hud, senor, brosk).<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Klinische_Empfehlungen\"><\/span>Kliniska rekommendationer<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Fotobiomodulering \u00e4r den f\u00f6rsta icke-invasiva behandlingsmodaliteten med bevisad klinisk effekt inom minst 7 olika medicinska discipliner. Styrkan i bevisen varierar: De mest robusta uppgifterna g\u00e4ller oral mukosit (MASCC\/ISOO-riktlinjerna), s\u00e5rl\u00e4kning (metaanalyser LoE I) och muskelregenerering inom idrott. Omr\u00e5dena hj\u00e4rna\/neurologi och AMD \u00e4r mycket lovande, men \u00e4r fortfarande under utveckling.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Allgemeine_Dosierungsregeln_Konsensus\"><\/span>Allm\u00e4nna doseringsregler (konsensus)<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Absorberad dos<\/strong><br>5-50 joule totalt per session (riktlinje: ~25 J)<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>V\u00e5gl\u00e4ngd per m\u00e5l<\/strong><br>660 nm f\u00f6r hud\/yta<br>810-850 nm f\u00f6r muskler\/leder\/djup v\u00e4vnad<br>1.050-1.064 nm f\u00f6r hj\u00e4rnan<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Effektt\u00e4thet per djup<\/strong><br>Hud 6-50 mW\/cm\u00b2<br>Muskler 50-100 mW\/cm\u00b2<br>Hj\u00e4rna (transkraniell) 25-285 mW\/cm\u00b2<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Observera bifasiska signaler<\/strong><br>H\u00f6gre doser \u00e4r inte automatiskt b\u00e4ttre.<br>- Hud: max. 20 J\/cm\u00b2<br>- Neuroner: max. 10 J\/cm\u00b2 p\u00e5 m\u00e5lv\u00e4vnaden<br>- f\u00f6r muskler: max. 30-50 J\/cm\u00b2<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Kombinerade enheter<\/strong> - 660 + 850 nm ger bredast spektrum; kr\u00e4ver ~50% mer behandlingstid<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Behandlingsintervall<\/strong><br>Dagligen till 3\u00d7\/vecka; paus rekommenderas var 1-2:e dag f\u00f6r cell\u00e5terh\u00e4mtning<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Evidenzstarke_nach_Bereich\"><\/span>Styrkan i bevisen per omr\u00e5de<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Mycket stark (LoE I, WALT\/MASCC-riktlinjer)<\/strong><br>- Mukosit vid cancer<br>- S\u00e5rl\u00e4kning<br>- Kollagen\/hud<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Stark (LoE I, metaanalyser)<\/strong><br>- Muskelregenerering<br>- Fibromyalgi<br>- AMD<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>M\u00e5ttlig (LoE II, RCTs)<\/strong><br>- Artros i kn\u00e4<br>- neuropatisk sm\u00e4rta<br>- Kognition (transkraniell)<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Tidigt (prekliniskt\/pilot)<\/strong><br>- Avgiftning, lymfsystem<br>- L\u00e5ngsiktig cancer\u00f6verlevnad<br>- 1.064 nm djupa hj\u00e4rnstrukturer<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Kontakt_zu_PBM-Anwendern_%E2%80%93_Arzte_Kliniken\"><\/span>Kontakt med PBM-anv\u00e4ndare - l\u00e4kare\/kliniker<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Augenheilkunde_%E2%80%93_Trockene_AMD_Makuladegeneration\"><\/span>Oftalmologi - Torr AMD (makuladegeneration)<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Detta \u00e4r det kliniskt mest avancerade och regulatoriskt s\u00e4kraste omr\u00e5det. Enheten&nbsp;<strong>Valeda (LumiThera)<\/strong>&nbsp;\u00e4r CE-certifierad och har godk\u00e4nts i Europa sedan 2018; FDA-godk\u00e4nd sedan november 2024.<\/p>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Leverant\u00f6r<\/th><th>Plats<\/th><th>l\u00e4nk<\/th><\/tr><\/thead><tbody><tr><td><strong>Centrum f\u00f6r makula och retina<\/strong>&nbsp;(Prof Dr Hakan Kaymak - en av v\u00e4rldens mest erfarna anv\u00e4ndare, utf\u00f6r ~10 % av alla PBM-behandlingar i v\u00e4rlden)<\/td><td>D\u00fcsseldorf<\/td><td><a href=\"https:\/\/augenchirurgie.clinic\/behandlungen\/photobiomodulation\" target=\"_blank\" rel=\"noopener\">\u00f6gonl\u00e4karmottagning.klinik<\/a><\/td><\/tr><tr><td><strong>\u00d6gonl\u00e4kare Witten<\/strong>&nbsp;(Dr Riha) - en av de f\u00f6rsta mottagningarna i Tyskland<\/td><td>Witten \/ NRW<\/td><td><a href=\"https:\/\/www.augenarzt-witten.de\/photobiomodulation\/\" target=\"_blank\" rel=\"noopener\">augenarzt-witten.de<\/a><\/td><\/tr><tr><td><strong>\u00d6gonl\u00e4kare M\u00fcnchen<\/strong>&nbsp;(Dr Augsten)<\/td><td>M\u00fcnchen<\/td><td><a href=\"https:\/\/www.augenarzt-muc.de\/netzhaut\/behandlung\/valeda\/\" target=\"_blank\" rel=\"noopener\">\u00f6gonl\u00e4kare-muc.de<\/a><\/td><\/tr><tr><td><strong>\u00d6gonl\u00e4kare Gerl &amp; Kollegor<\/strong>&nbsp;(Valeda-programmet)<\/td><td>M\u00fcnchen<\/td><td><a href=\"https:\/\/www.augenklinik.de\/behandlung\/valeda\" target=\"_blank\" rel=\"noopener\">eyeclinic.com<\/a><\/td><\/tr><tr><td><strong>Dr Riha \u00d6gonl\u00e4kare<\/strong><\/td><td>Wien \/ AT<\/td><td><a href=\"https:\/\/dr-riha.com\/photobiomodulation\/\" target=\"_blank\" rel=\"noopener\">dr-riha.com<\/a><\/td><\/tr><tr><td><strong>\u00d6gonl\u00e4kare Bern<\/strong>&nbsp;(CH)<\/td><td>Bern \/ CH<\/td><td><a href=\"https:\/\/www.augenaerzte-bern.ch\/leistungen\/photobiomodulation-bei-altersbedingter-makuladegeneration\/\" target=\"_blank\" rel=\"noopener\">oftalmologer-bern.ch<\/a><\/td><\/tr><tr><td><strong>Berns \u00f6gonklinik<\/strong>&nbsp;(Prof Garweg)<\/td><td>Bern \/ CH<\/td><td><a href=\"https:\/\/augenklinik-bern.ch\/fachpublikum\/amd-sprechstunde\/\" target=\"_blank\" rel=\"noopener\">\u00f6gonklinik-bern.ch<\/a><\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Obs!<\/strong>\u00a0Kostnaderna t\u00e4cks i allm\u00e4nhet inte av den lagstadgade sjukf\u00f6rs\u00e4kringen (IGeL).<br>LumiThera erbjuder en s\u00f6kmotor f\u00f6r andra Valeda-center p\u00e5 sin webbplats.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Onkologie_%E2%80%93_Orale_Mukositis_Chemo-Strahlentherapiefolge\"><\/span>Onkologi - Oral mukosit (konsekvens av kemoterapi\/str\u00e5lbehandling)<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">PBM f\u00f6r f\u00f6rebyggande och behandling av inflammation i munslemhinnan \u00e4r riktlinjebaserad (MASCC\/ISOO) och integreras alltmer i onkologiska st\u00f6djande v\u00e5rdprogram. En europeisk klinisk riktlinje fastst\u00e4lldes f\u00f6r f\u00f6rsta g\u00e5ngen 2025\/2026.<\/p>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Leverant\u00f6r<\/th><th>Varsel<\/th><th>l\u00e4nk<\/th><\/tr><\/thead><tbody><tr><td><strong>rj-laser.com<\/strong>&nbsp;- Plattform f\u00f6r dental laserterapi med kliniska protokoll f\u00f6r mukosit<\/td><td>Specialistportal DE\/AT\/CH<\/td><td><a href=\"https:\/\/rj-laser.com\/de\/lasertherapie-mukositis-chemotherapieinduziert\" target=\"_blank\" rel=\"noopener\">rj-laser.com<\/a><\/td><\/tr><tr><td><strong>Informationstj\u00e4nst f\u00f6r cancer (KID)<\/strong><\/td><td>Rekommenderar starkt PBM som ett alternativ f\u00f6r mukosit vid underst\u00f6djande behandling<\/td><td><a href=\"https:\/\/www.krebsinformationsdienst.de\/fileadmin\/pdf-dateien\/informationsblaetter\/iblatt-mukositis-bei-krebs.pdf\" target=\"_blank\" rel=\"noopener\">krebsinformationsdienst.de<\/a><\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">De specifika kliniker i Tyskland som rutinm\u00e4ssigt erbjuder PBM f\u00f6r mukosit informerar s\u00e4llan om detta p\u00e5 sina patientwebbplatser. Behandlingen sker vanligtvis som en del av tandv\u00e5rden p\u00e5 stora onkologiska centra (t.ex. universitetssjukhus).<br>Det \u00e4r l\u00e4mpligt att kontakta den behandlande onkologiska kliniken eller k\u00e4kkirurgen.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Dermatologie_%E2%80%93_Haut_Wundheilung_Akne_Psoriasis\"><\/span>Dermatologi - hud, s\u00e5rl\u00e4kning, akne, psoriasis<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">PBM med LED-ljusbehandling \u00e4r etablerat p\u00e5 m\u00e5nga dermatologiska mottagningar och estetiska kliniker.<\/p>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Leverant\u00f6r<\/th><th>Plats<\/th><th>l\u00e4nk<\/th><\/tr><\/thead><tbody><tr><td><strong>Dermatologi Dr Friedl<\/strong>&nbsp;- LED-ljusbehandling (Medisol\u00ae) f\u00f6r akne, vitiligo, psoriasis, hud\u00e5ldrande, vit hudcancer (PDT)<\/td><td>\u00d6sterrike<\/td><td><a href=\"https:\/\/www.dermatologie-friedl.de\/leistungen\/aesthetische-medizin\/led-lichttherapie-mit-medisol-lampe\" target=\"_blank\" rel=\"noopener\">dermatologi-friedl.com<\/a><\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">Dessutom anv\u00e4nder m\u00e5nga estetiska dermatologipraktiker och lasercenter i Tyskland PBM (t.ex. med Fotona-system). Vi rekommenderar att du s\u00f6ker efter \u201eLED-ljusterapi dermatologi\u201c eller \u201ePBM-dermatolog\u201c med en plats.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Zahnmedizin_MKG-Chirurgie\"><\/span>Tandv\u00e5rd \/ maxillofacial kirurgi<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">PBM anv\u00e4nds ofta inom tandv\u00e5rden, t.ex. vid sm\u00e4rta i k\u00e4klederna (CMD), postoperativ s\u00e5rl\u00e4kning, implantat och mukosit. Ortodontister anv\u00e4nder&nbsp;<strong>OrthoPulse\u00ae-apparat<\/strong>&nbsp;f\u00f6r att p\u00e5skynda tandr\u00f6relser (sj\u00e4lvapplicering, ca 600 euro).<\/p>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Leverant\u00f6r \/ Portal<\/th><th>Varsel<\/th><th>l\u00e4nk<\/th><\/tr><\/thead><tbody><tr><td><strong>ZWP Online<\/strong>&nbsp;- \u00d6versikt \u00f6ver KFO-PBM<\/td><td>Portal f\u00f6r specialister<\/td><td><a href=\"https:\/\/www.zwp-online.info\/zwpnews\/wirtschaft-und-recht\/recht\/photobiomodulation-in-der-kieferorthopadie\" target=\"_blank\" rel=\"noopener\">zwp-online.info<\/a><\/td><\/tr><tr><td><strong>Fotona lasersystem<\/strong>&nbsp;(s\u00f6kning efter \u00e5terf\u00f6rs\u00e4ljare\/klinik m\u00f6jlig)<\/td><td>PBM f\u00f6r tandv\u00e5rd och sjukv\u00e5rd, LightWalker<\/td><td><a href=\"https:\/\/www.fotona.com\/de\/treatments\/6496\/photobiomodulation-und-schmerzbehandlung\/\" target=\"_blank\" rel=\"noopener\">fotona.com<\/a><\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Neurologie_Psychiatrie_%E2%80%93_Alzheimer_TBI_Depression_fruhe_Phase\"><\/span>Neurologi \/ Psykiatri - Alzheimers, TBI, depression (tidig fas)<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Detta omr\u00e5de genomg\u00e5r fortfarande kliniska pr\u00f6vningar. Det \u00e4r fortfarande s\u00e4llsynt med regelbundet godk\u00e4nda patienttj\u00e4nster i Tyskland, men de f\u00f6rsta centrumen och studierna finns redan.<\/p>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Leverant\u00f6r \/ Portal<\/th><th>Varsel<\/th><th>l\u00e4nk<\/th><\/tr><\/thead><tbody><tr><td><strong>PBM-Fotobiomodulering.eu<\/strong>&nbsp;- Europeisk informationsportal med praktisk \u00f6versikt<\/td><td>DACH-regionen<\/td><td><a href=\"https:\/\/pbm-photobiomodulation.eu\/PBM\" target=\"_blank\" rel=\"noopener\">pbm-photobiomodulation.eu<\/a><\/td><\/tr><tr><td><strong>Neurofeedback Luxemburg<\/strong>&nbsp;- informerar om neurologiska PBM-applikationer<\/td><td>LU\/DACH<\/td><td><a href=\"https:\/\/neurofeedback-luxembourg.com\/de\/photobiomodulation-ein-umfassender-leitfaden-fur-lichttherapievorteile\/\" target=\"_blank\" rel=\"noopener\">neurofeedback-luxemburg.com<\/a><\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Allgemeine_Suchwerkzeuge\"><\/span>Allm\u00e4nna s\u00f6kverktyg<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Tillverkaren LumiThera erbjuder p\u00e5 sin webbplats en\u00a0<strong>S\u00f6k efter plats<\/strong>\u00a0f\u00f6r Valeda-rutiner:\u00a0<a href=\"https:\/\/www.lumithera.com\/\" target=\"_blank\" rel=\"noopener\">lumithera.com<\/a><\/li>\n\n\n\n<li>Portalen\u00a0<strong>pbm-photobiomodulation.eu<\/strong>\u00a0listar europeiska metoder<\/li>\n\n\n\n<li>De\u00a0<strong>V\u00e4rldsorganisationen f\u00f6r laserterapi (WALT)<\/strong>\u00a0erbjuder en global s\u00f6kning efter terapeuter<\/li>\n<\/ul>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Viktig anm\u00e4rkning:<\/strong>\u00a0Kostnadst\u00e4ckning genom lagstadgade sjukf\u00f6rs\u00e4kringskassor \u00e4r \u00e4nnu inte reglerad i Tyskland f\u00f6r de flesta PBM-indikationer (med undantag f\u00f6r st\u00f6djande onkologi i vissa centra).<br>PBM anv\u00e4nds fr\u00e4mst som\u00a0<strong>IGeL-tj\u00e4nst<\/strong>\u00a0faktureras privat.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<div style=\"height:100px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<p class=\"wp-block-paragraph\"><em>Dokumentet baseras p\u00e5 vetenskapligt granskad litteratur fr\u00e5n PubMed, PMC, Frontiers, MDPI, Springer och Nature under perioden 2019 till 02.2026. <\/em><br>Visas <em>Parametrarna \u00e4r h\u00e4mtade fr\u00e5n kliniska studier och WALT\/MASCC:s rekommendationer.<\/em><\/p>\n\n\n\n<div style=\"height:100px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\">\n<p class=\"wp-block-paragraph\">Allt inneh\u00e5ll har samvetsgrant unders\u00f6kts och \u00e5terspeglar det aktuella (02.2026) publicerade kunskapsl\u00e4get. Den \u00e4r endast avsedd som information och ers\u00e4tter inte en professionell medicinsk konsultation.<br><br>L\u00e4nkade studier ger ut\u00f6varen ytterligare medicinsk och vetenskaplig information.<\/p>\n<\/blockquote>","protected":false},"excerpt":{"rendered":"<p>Umfassende Studien\u00fcbersicht 2023\u20132025 Einleitung Photobiomodulation (PBM), auch bekannt als Low-Level-Lasertherapie (LLLT), ist eine nicht-invasive therapeutische Methode, die Licht bestimmter Wellenl\u00e4ngen nutzt, um biologische Prozesse in lebendem Gewebe zu stimulieren.Prim\u00e4rer Mechanismus ist die Absorption von Photonen durch den mitochondrialen Photoakzeptor Cytochrom-c-Oxidase (CCO), was die ATP-Synthese steigert, reaktive Sauerstoffspezies moduliert und eine Kaskade zellul\u00e4rer Regenerationsprozesse anst\u00f6\u00dft. Das&hellip;&nbsp;<a href=\"https:\/\/csiag.de\/sv\/blog\/2026\/02\/18\/photobiomodulation-pbm\/\" rel=\"bookmark\">L\u00e4s mer \"<span class=\"screen-reader-text\">Fotobiomodulering (PBM)<\/span><\/a><\/p>","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_lmt_disableupdate":"","_lmt_disable":"","neve_meta_sidebar":"","neve_meta_container":"","neve_meta_enable_content_width":"","neve_meta_content_width":0,"neve_meta_title_alignment":"","neve_meta_author_avatar":"","neve_post_elements_order":"","neve_meta_disable_header":"","neve_meta_disable_footer":"","neve_meta_disable_title":"","footnotes":""},"categories":[1078,354],"tags":[],"class_list":["post-12784","post","type-post","status-publish","format-standard","hentry","category-medizin","category-medizin-gesundheit"],"acf":[],"modified_by":"Achim Goerner","_links":{"self":[{"href":"https:\/\/csiag.de\/sv\/wp-json\/wp\/v2\/posts\/12784","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/csiag.de\/sv\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/csiag.de\/sv\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/csiag.de\/sv\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/csiag.de\/sv\/wp-json\/wp\/v2\/comments?post=12784"}],"version-history":[{"count":1,"href":"https:\/\/csiag.de\/sv\/wp-json\/wp\/v2\/posts\/12784\/revisions"}],"predecessor-version":[{"id":13627,"href":"https:\/\/csiag.de\/sv\/wp-json\/wp\/v2\/posts\/12784\/revisions\/13627"}],"wp:attachment":[{"href":"https:\/\/csiag.de\/sv\/wp-json\/wp\/v2\/media?parent=12784"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/csiag.de\/sv\/wp-json\/wp\/v2\/categories?post=12784"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/csiag.de\/sv\/wp-json\/wp\/v2\/tags?post=12784"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}